Stay updated on Tagraxofusp in CD123+ AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry (v3.6.3) was added to the study's history, representing an update to the page’s record, while the previous revision (v3.6.2) was removed from the history.SummaryDifference0.1%

- Check23 days agoChange DetectedThe record history now includes a new revision entry: v3.6.2, replacing the previous v3.6.0 entry. This marks an updated version of the study record without changing its substantive details.SummaryDifference0.1%

- Check37 days agoChange DetectedEnrollment status changed to closed, indicating the study is no longer seeking participants. The record version was updated to Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.7%

- Check44 days agoChange DetectedThe record history shows a new revision label v3.5.5, indicating an administrative page version update. The update does not modify the study data or visible content beyond versioning.SummaryDifference0.1%

- Check66 days agoChange DetectedThe change set adds a new revision entry, v3.5.4, and removes the prior revision, v3.5.3, from the study record history. This reflects an update to the page's revision history rather than a change to the study data.SummaryDifference0.1%

- Check87 days agoChange DetectedA site release/version update is reflected on the page (moving from one revision identifier to the next) without indicating any change to the trial record itself.SummaryDifference0.1%

Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.